Progyny, Inc. (PGNY)
PGNY Stock Price Chart
Explore Progyny, Inc. interactive price chart. Choose custom timeframes to analyze PGNY price movements and trends.
PGNY Company Profile
Discover essential business fundamentals and corporate details for Progyny, Inc. (PGNY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
25 Oct 2019
Employees
675.00
Website
https://www.progyny.comCEO
David J. Schlanger
Description
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
PGNY Financial Timeline
Browse a chronological timeline of Progyny, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is $0.34, while revenue estimate is $348.73m.
Earnings released on 7 May 2026
EPS came in at $0.30 surpassing the estimated $0.26 by +17.19%, while revenue for the quarter reached $328.50m , beating expectations by +0.62%.
Earnings released on 26 Feb 2026
EPS came in at $0.15 surpassing the estimated $0.15 by +2.04%, while revenue for the quarter reached $318.40m , beating expectations by +3.57%.
Earnings released on 6 Nov 2025
EPS came in at $0.45 surpassing the estimated $0.39 by +15.38%, while revenue for the quarter reached $313.35m , missing expectations by -0.29%.
Earnings released on 7 Aug 2025
EPS came in at $0.48 surpassing the estimated $0.44 by +9.09%, while revenue for the quarter reached $332.87m , beating expectations by +11.24%.
Earnings released on 8 May 2025
EPS came in at $0.48 surpassing the estimated $0.45 by +6.67%, while revenue for the quarter reached $324.04m , beating expectations by +5.27%.
Earnings released on 27 Feb 2025
EPS came in at $0.42 surpassing the estimated $0.37 by +13.51%, while revenue for the quarter reached $298.43m , beating expectations by +7.62%.
Earnings released on 12 Nov 2024
EPS came in at $0.40 surpassing the estimated $0.37 by +8.11%, while revenue for the quarter reached $286.63m , beating expectations by +3.43%.
Earnings released on 6 Aug 2024
EPS came in at $0.43 surpassing the estimated $0.36 by +19.44%, while revenue for the quarter reached $304.09m , missing expectations by -0.44%.
Earnings released on 9 May 2024
EPS came in at $0.39 surpassing the estimated $0.14 by +178.57%, while revenue for the quarter reached $278.08m , missing expectations by -3.93%.
Earnings released on 27 Feb 2024
EPS came in at $0.32 surpassing the estimated $0.11 by +190.91%, while revenue for the quarter reached $269.94m , missing expectations by -1.52%.
Earnings released on 7 Nov 2023
EPS came in at $0.16 surpassing the estimated $0.12 by +33.33%, while revenue for the quarter reached $280.89m , beating expectations by +2.64%.
Earnings released on 3 Aug 2023
EPS came in at $0.15 surpassing the estimated $0.10 by +50.00%, while revenue for the quarter reached $279.37m , beating expectations by +6.67%.
Earnings released on 8 May 2023
EPS came in at $0.18 surpassing the estimated $0.07 by +157.14%, while revenue for the quarter reached $258.39m , beating expectations by +5.17%.
Earnings released on 27 Feb 2023
EPS came in at $0.03 surpassing the estimated $0.01 by +157.07%, while revenue for the quarter reached $214.32m , beating expectations by +1.20%.
Earnings released on 3 Nov 2022
EPS came in at $0.13 surpassing the estimated $0.05 by +160.00%, while revenue for the quarter reached $205.37m , beating expectations by +5.57%.
Earnings released on 4 Aug 2022
EPS came in at $0.09 surpassing the estimated $0.05 by +80.00%, while revenue for the quarter reached $195.00m , beating expectations by +2.36%.
Earnings released on 5 May 2022
EPS came in at $0.05 surpassing the estimated $0.01 by +525.00%, while revenue for the quarter reached $172.22m , beating expectations by +3.02%.
Earnings released on 28 Feb 2022
EPS came in at $0.15 surpassing the estimated $0.04 by +316.67%, while revenue for the quarter reached $127.55m , missing expectations by -5.26%.
Earnings released on 4 Nov 2021
EPS came in at $0.17 surpassing the estimated $0.06 by +183.33%, while revenue for the quarter reached $122.28m , missing expectations by -5.18%.
Earnings released on 5 Aug 2021
EPS came in at $0.19 surpassing the estimated $0.08 by +137.50%, while revenue for the quarter reached $128.65m , beating expectations by +7.74%.
PGNY Stock Performance
Access detailed PGNY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
